Your browser doesn't support javascript.
loading
The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network.
Marsch, Lisa A; Campbell, Aimee; Campbell, Cynthia; Chen, Ching-Hua; Ertin, Emre; Ghitza, Udi; Lambert-Harris, Chantal; Hassanpour, Saeed; Holtyn, August F; Hser, Yih-Ing; Jacobs, Petra; Klausner, Jeffrey D; Lemley, Shea; Kotz, David; Meier, Andrea; McLeman, Bethany; McNeely, Jennifer; Mishra, Varun; Mooney, Larissa; Nunes, Edward; Stafylis, Chrysovalantis; Stanger, Catherine; Saunders, Elizabeth; Subramaniam, Geetha; Young, Sean.
Afiliação
  • Marsch LA; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA. Electronic address: Lisa.A.Marsch@
  • Campbell A; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA; Department of Psychiatry, Columbia University, 1051 Riverside Dr, New York, NY 10032, USA.
  • Campbell C; Kaiser Permanente Division of Research, 2000 Broadway, Oakland, CA 94612, USA.
  • Chen CH; Computational Health Behavior and Decision Science Research, IBM Thomas J. Watson Research, 1101 Kitchawan Rd, Yorktown Heights, NY 10598, USA.
  • Ertin E; The Ohio State University College of Engineering, 2070 Neil Ave, Columbus, OH 43210, USA.
  • Ghitza U; The National Institute on Drug Abuse, 6001 Executive Blvd, Rockville, MD 20852, USA.
  • Lambert-Harris C; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA.
  • Hassanpour S; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA.
  • Holtyn AF; Psychiatry and Behavioral Sciences, Johns Hopkins Medicine, 5255 Loughboro Road, N.W., Washington, DC 20016, USA.
  • Hser YI; Department of Psychiatry and Behavioral Sciences at the UCLA Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., Ste. 200, Los Angeles, CA 90025, USA.
  • Jacobs P; The National Institute on Drug Abuse, 6001 Executive Blvd, Rockville, MD 20852, USA.
  • Klausner JD; Epidemiology UCLA Fielding School of Public Health, Box 951772, Los Angeles, CA 90095-1772, USA.
  • Lemley S; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA.
  • Kotz D; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA.
  • Meier A; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA.
  • McLeman B; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA.
  • McNeely J; Department of Population Health, Department of Medicine, NYU School of Medicine, 227 East 30th Street, Seventh Floor, New York, NY 10016, USA.
  • Mishra V; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA.
  • Mooney L; Resnick Neuropsychiatric Hospital at UCLA, Ronald Reagan UCLA Medical Center, 150 Medical Plaza Driveway, Los Angeles, CA 90095, USA.
  • Nunes E; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA; Department of Psychiatry, Columbia University, 1051 Riverside Dr, New York, NY 10032, USA.
  • Stafylis C; Department of Medicine, UCLA, 100 Medical Plaza Driveway, Los Angeles, CA 90095, USA.
  • Stanger C; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA.
  • Saunders E; Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, 46 Centerra Dr, Lebanon, NH 03766, USA.
  • Subramaniam G; The National Institute on Drug Abuse, 6001 Executive Blvd, Rockville, MD 20852, USA.
  • Young S; University of California, Irvine, UC Institute for Prediction Technology, Donald Bren Hall: 6135, Irvine, CA 92697, USA.
J Subst Abuse Treat ; 112S: 4-11, 2020 03.
Article em En | MEDLINE | ID: mdl-32220409
The application of digital technologies to better assess, understand, and treat substance use disorders (SUDs) is a particularly promising and vibrant area of scientific research. The National Drug Abuse Treatment Clinical Trials Network (CTN), launched in 1999 by the U.S. National Institute on Drug Abuse, has supported a growing line of research that leverages digital technologies to glean new insights into SUDs and provide science-based therapeutic tools to a diverse array of persons with SUDs. This manuscript provides an overview of the breadth and impact of research conducted in the realm of digital health within the CTN. This work has included the CTN's efforts to systematically embed digital screeners for SUDs into general medical settings to impact care models across the nation. This work has also included a pivotal multi-site clinical trial conducted on the CTN platform, whose data led to the very first "prescription digital therapeutic" authorized by the U.S. Food and Drug Administration (FDA) for the treatment of SUDs. Further CTN research includes the study of telehealth to increase capacity for science-based SUD treatment in rural and under-resourced communities. In addition, the CTN has supported an assessment of the feasibility of detecting cocaine-taking behavior via smartwatch sensing. And, the CTN has supported the conduct of clinical trials entirely online (including the recruitment of national and hard-to-reach/under-served participant samples online, with remote intervention delivery and data collection). Further, the CTN is supporting innovative work focused on the use of digital health technologies and data analytics to identify digital biomarkers and understand the clinical trajectories of individuals receiving medications for opioid use disorder (OUD). This manuscript concludes by outlining the many potential future opportunities to leverage the unique national CTN research network to scale-up the science on digital health to examine optimal strategies to increase the reach of science-based SUD service delivery models both within and outside of healthcare.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / National Institute on Drug Abuse (U.S.) Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Subst Abuse Treat Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / National Institute on Drug Abuse (U.S.) Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Subst Abuse Treat Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2020 Tipo de documento: Article